Vertex Pharmaceuticals continues to strengthen its global commercial footprint by expanding beyond its core cystic fibrosis portfolio into novel therapeutic areas like gene therapy, pain management, and rare endocrinology.
Vertex Pharmaceuticals continues to strengthen its global commercial footprint by expanding beyond its core cystic fibrosis portfolio into novel therapeutic areas like gene therapy, pain management, and rare endocrinology.